Outcomes of coronary artery bypass grafting in patients with connective tissue diseases

Thomas Birdas, Jeffrey T. Landis, David Haybron, Debbie Evers, Pavlos K. Papasavas, Philip F. Caushaj

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Coronary artery disease represents a significant cause of morbidity and mortality in patients with connective tissue disease. Few reports exist on the results of surgical management of coronary artery disease in these patients. Methods. The medical records of patients with connective tissue diseases who underwent coronary artery bypass grafting at our institution between 1995 and 2002 were reviewed for demographic data, perioperative variables, and postoperative complications. The results were compared with data from The Society of Thoracic Surgeons database. Results. Forty-four patients were identified from a total of 5,496 cases during the study period (0.8%). There were 35 patients with rheumatoid arthritis, 8 with systemic lupus erythematosus, and 1 with scleroderma. Patients with connective tissue diseases were more likely to be women and use immunomodulating agents. They also had a higher incidence of Canadian Cardiovascular Society class IV angina, need for inotropic agents, need for intraaortic balloon pulsation, use of blood transfusions, and leg wound infections. The use of steroids or other immunomodulating agents was associated with increased postoperative complications. Mean follow-up was 35 months. The overall survival and freedom from reintervention at 3 years were 89% and 75%, respectively. Conclusions. Coronary artery bypass grafting is a safe treatment modality in patients with connective tissue diseases, with acceptable early results. Wound complications may be a problem in this patient population. Midterm results are less favorable, and reinterventions are frequently required.

Original languageEnglish (US)
Pages (from-to)1610-1614
Number of pages5
JournalAnnals of Thoracic Surgery
Volume79
Issue number5
DOIs
StatePublished - May 2005
Externally publishedYes

Fingerprint

Connective Tissue Diseases
Coronary Artery Bypass
Coronary Artery Disease
Wound Infection
Blood Transfusion
Systemic Lupus Erythematosus
Medical Records
Rheumatoid Arthritis
Leg
Steroids
Demography
Databases
Morbidity
Survival
Mortality
Incidence
Wounds and Injuries

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Outcomes of coronary artery bypass grafting in patients with connective tissue diseases. / Birdas, Thomas; Landis, Jeffrey T.; Haybron, David; Evers, Debbie; Papasavas, Pavlos K.; Caushaj, Philip F.

In: Annals of Thoracic Surgery, Vol. 79, No. 5, 05.2005, p. 1610-1614.

Research output: Contribution to journalArticle

Birdas, Thomas ; Landis, Jeffrey T. ; Haybron, David ; Evers, Debbie ; Papasavas, Pavlos K. ; Caushaj, Philip F. / Outcomes of coronary artery bypass grafting in patients with connective tissue diseases. In: Annals of Thoracic Surgery. 2005 ; Vol. 79, No. 5. pp. 1610-1614.
@article{6560ad2656264dbc9cbb77858484232a,
title = "Outcomes of coronary artery bypass grafting in patients with connective tissue diseases",
abstract = "Background. Coronary artery disease represents a significant cause of morbidity and mortality in patients with connective tissue disease. Few reports exist on the results of surgical management of coronary artery disease in these patients. Methods. The medical records of patients with connective tissue diseases who underwent coronary artery bypass grafting at our institution between 1995 and 2002 were reviewed for demographic data, perioperative variables, and postoperative complications. The results were compared with data from The Society of Thoracic Surgeons database. Results. Forty-four patients were identified from a total of 5,496 cases during the study period (0.8{\%}). There were 35 patients with rheumatoid arthritis, 8 with systemic lupus erythematosus, and 1 with scleroderma. Patients with connective tissue diseases were more likely to be women and use immunomodulating agents. They also had a higher incidence of Canadian Cardiovascular Society class IV angina, need for inotropic agents, need for intraaortic balloon pulsation, use of blood transfusions, and leg wound infections. The use of steroids or other immunomodulating agents was associated with increased postoperative complications. Mean follow-up was 35 months. The overall survival and freedom from reintervention at 3 years were 89{\%} and 75{\%}, respectively. Conclusions. Coronary artery bypass grafting is a safe treatment modality in patients with connective tissue diseases, with acceptable early results. Wound complications may be a problem in this patient population. Midterm results are less favorable, and reinterventions are frequently required.",
author = "Thomas Birdas and Landis, {Jeffrey T.} and David Haybron and Debbie Evers and Papasavas, {Pavlos K.} and Caushaj, {Philip F.}",
year = "2005",
month = "5",
doi = "10.1016/j.athoracsur.2004.10.052",
language = "English (US)",
volume = "79",
pages = "1610--1614",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Outcomes of coronary artery bypass grafting in patients with connective tissue diseases

AU - Birdas, Thomas

AU - Landis, Jeffrey T.

AU - Haybron, David

AU - Evers, Debbie

AU - Papasavas, Pavlos K.

AU - Caushaj, Philip F.

PY - 2005/5

Y1 - 2005/5

N2 - Background. Coronary artery disease represents a significant cause of morbidity and mortality in patients with connective tissue disease. Few reports exist on the results of surgical management of coronary artery disease in these patients. Methods. The medical records of patients with connective tissue diseases who underwent coronary artery bypass grafting at our institution between 1995 and 2002 were reviewed for demographic data, perioperative variables, and postoperative complications. The results were compared with data from The Society of Thoracic Surgeons database. Results. Forty-four patients were identified from a total of 5,496 cases during the study period (0.8%). There were 35 patients with rheumatoid arthritis, 8 with systemic lupus erythematosus, and 1 with scleroderma. Patients with connective tissue diseases were more likely to be women and use immunomodulating agents. They also had a higher incidence of Canadian Cardiovascular Society class IV angina, need for inotropic agents, need for intraaortic balloon pulsation, use of blood transfusions, and leg wound infections. The use of steroids or other immunomodulating agents was associated with increased postoperative complications. Mean follow-up was 35 months. The overall survival and freedom from reintervention at 3 years were 89% and 75%, respectively. Conclusions. Coronary artery bypass grafting is a safe treatment modality in patients with connective tissue diseases, with acceptable early results. Wound complications may be a problem in this patient population. Midterm results are less favorable, and reinterventions are frequently required.

AB - Background. Coronary artery disease represents a significant cause of morbidity and mortality in patients with connective tissue disease. Few reports exist on the results of surgical management of coronary artery disease in these patients. Methods. The medical records of patients with connective tissue diseases who underwent coronary artery bypass grafting at our institution between 1995 and 2002 were reviewed for demographic data, perioperative variables, and postoperative complications. The results were compared with data from The Society of Thoracic Surgeons database. Results. Forty-four patients were identified from a total of 5,496 cases during the study period (0.8%). There were 35 patients with rheumatoid arthritis, 8 with systemic lupus erythematosus, and 1 with scleroderma. Patients with connective tissue diseases were more likely to be women and use immunomodulating agents. They also had a higher incidence of Canadian Cardiovascular Society class IV angina, need for inotropic agents, need for intraaortic balloon pulsation, use of blood transfusions, and leg wound infections. The use of steroids or other immunomodulating agents was associated with increased postoperative complications. Mean follow-up was 35 months. The overall survival and freedom from reintervention at 3 years were 89% and 75%, respectively. Conclusions. Coronary artery bypass grafting is a safe treatment modality in patients with connective tissue diseases, with acceptable early results. Wound complications may be a problem in this patient population. Midterm results are less favorable, and reinterventions are frequently required.

UR - http://www.scopus.com/inward/record.url?scp=18144390145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144390145&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2004.10.052

DO - 10.1016/j.athoracsur.2004.10.052

M3 - Article

VL - 79

SP - 1610

EP - 1614

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -